Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139

• Published in: ACS medicinal chemistry letters Vol. 2; no. 4; pp. 303 - 306
• Main Authors: Shi, Feng, Shen, Jing Kang, Chen, Danqi, Fog, Karina, Thirstrup, Kenneth, Hentzer, Morten, Karlsson, Jens-Jakob, Menon, Veena, Jones, Kenneth A, Smith, Kelli E, Smith, Garrick
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 14.04.2011
• Subjects: Letter; Orphan GPR-139; CNS; hydrazinecarboxamide; agonists; G-protein coupled receptor
• ISSN: 1948-5875; 1948-5875
• DOI: 10.1021/ml100293q

GPR139 is an orphan G-protein coupled receptor (GPCR) which is primarily expressed in the central nervous system (CNS). In order to explore the biological function of this receptor, selective tool compounds are required. A screening campaign identified compound 1a as a high potency GPR139 agonist with an EC50 = 39 nM in a calcium mobilization assay in CHO-K1 cells stably expressing the GPR139 receptor. In the absence of a known endogenous ligand, the maximum effect was set as 100% for 1a. Screening against 90 diverse targets revealed no cross-reactivity issues. Assessment of the pharmacokinetic properties showed limited utility as in vivo tool compound in rat with a poor whole brain exposure of 61 ng/g and a brain/plasma (b/p) ratio of 0.03. Attempts to identify a more suitable analogue identified the des-nitrogen analogue 1s with a reduced polar surface area of 76.7 Å2 and an improved b/p ratio of 2.8. The whole brain exposure remained low at 95 ng/g due to a low plasma exposure.